Date: 2026-08-28
Repository: MSKazemi/idkmesh
The project owner asked to continue work on IDKMesh after activating the ACE (Autocatalytic Community Evolution) bootstrap cohort and scheduling a weekly cohort check.
The standing project rule remains that substantive project chats should be distilled into the public repository rather than remaining private conversational context.
At the start of this continuation:
ACE was found.Because several other project tracks were active concurrently, this continuation intentionally avoided modifying those product or repository-structure branches.
The next ACE step should be observability, not more seed creation.
The project needs to distinguish the following states:
interest -> claim -> candidate PR -> merged candidate -> verified descendant
Raw activity is not community reproduction evidence.
Branch: ace-cohort-observer-v0
.github/workflows/ace-cohort-observer.ymlA metadata-only GitHub workflow that:
/claim, external assignment, or a cross-referenced PR as a claim signal;ace:verified-descendant label before a merged candidate contributes to ACE reproduction evidence;[ACE] Bootstrap Cohort Observatory issue;HOLD_COHORT_1 or EVALUATE_COHORT_2 but never creates Cohort 2 automatically;docs/community/ACE_COHORT_OBSERVER.mdDocuments the funnel, evidence rules, temporary seed reproduction ratio, capacity-aware expansion recommendation, anti-Goodhart rules, and security boundary.
Adds an optional lineage field such as:
ACE-Seed: #24
This makes candidate lineage easier for contributors and reviewers to express without introducing a database.
Until issue #25 defines a general parent→descendant lineage format, the observer reports:
SeedReproductionRatio = verified descendant PRs / Growth Seeds
This is explicitly not the full ACE community reproduction number:
R_community(W) = verified descendant contributions / verified parent contributions
The distinction prevents the project from overstating evidence during the bootstrap experiment.
Do not create Cohort 2 merely because the repository is active. Expansion should be evidence- and capacity-gated.